Total Payments
$3,264
2024 Payments
$558.60
Companies
18
Transactions
65
Medicare Patients
1,619
Medicare Billing
$140,446
Payment Breakdown by Category
Food & Beverage$1,549 (47.4%)
Education$1,304 (39.9%)
Travel$264.71 (8.1%)
Other$146.68 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,549 | 62 | 47.4% |
| Education | $1,304 | 1 | 39.9% |
| Travel and Lodging | $264.71 | 1 | 8.1% |
| Long term medical supply or device loan | $146.68 | 1 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medinc of Texas | $1,304 | 1 | $0 (2019) |
| MEDLINE INDUSTRIES LP | $554.95 | 4 | $0 (2023) |
| Stryker Corporation | $232.81 | 8 | $0 (2024) |
| ABBVIE INC. | $179.75 | 16 | $0 (2024) |
| Integra LifeSciences Corporation | $146.68 | 1 | $0 (2024) |
| Paratek Pharmaceuticals, Inc. | $133.87 | 7 | $0 (2023) |
| Reapplix Inc. | $128.08 | 1 | $0 (2023) |
| Kerecis Limited | $97.61 | 2 | $0 (2023) |
| Horizon Therapeutics plc | $81.24 | 5 | $0 (2023) |
| Smith+Nephew, Inc. | $80.37 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $558.60 | 18 | Stryker Corporation ($193.32) |
| 2023 | $1,125 | 33 | MEDLINE INDUSTRIES LP ($554.95) |
| 2022 | $276.65 | 13 | Horizon Therapeutics plc ($63.07) |
| 2019 | $1,304 | 1 | Medinc of Texas ($1,304) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Stryker Corporation | DART-FIRE (Device) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 12/15/2024 | Stryker Corporation | DART-FIRE (Device) | Food and Beverage | In-kind items and services | $83.33 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 12/02/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/06/2024 | Stryker Corporation | DART-FIRE (Device) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 11/06/2024 | Stryker Corporation | DART-FIRE (Device) | Food and Beverage | In-kind items and services | $3.59 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 10/17/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $16.69 | General |
| 10/04/2024 | Stryker Corporation | AUGMENT INJECTABLE (Device) | Food and Beverage | In-kind items and services | $56.83 | General |
| Category: BONE SUBSTITUTES | ||||||
| 09/27/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Pharma Products | ||||||
| 09/03/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $14.32 | General |
| 08/01/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/08/2024 | Integra LifeSciences Corporation | ACell (Device) | Long term medical supply or device loan | In-kind items and services | $146.68 | General |
| Category: Recon-Skin and Wound | ||||||
| 06/18/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/24/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/17/2024 | Stryker Corporation | ACTISHIELD (Device) | Food and Beverage | In-kind items and services | $12.26 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 03/20/2024 | MIMEDX Group, Inc. | — | Food and Beverage | In-kind items and services | $21.48 | General |
| 03/13/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 01/19/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/14/2023 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/11/2023 | Nuo Therapeutics | — | Food and Beverage | Cash or cash equivalent | $13.40 | General |
| 11/15/2023 | ABBVIE INC. | DALVANCE (Drug), TEFLARO | Food and Beverage | In-kind items and services | $1.59 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/01/2023 | Innovation Technologies Inc | IRRISEPT (Device) | Food and Beverage | In-kind items and services | $34.71 | General |
| Category: JET LAVAGE DEVICE WITH CHG | ||||||
| 10/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: KRYSTEXXA | ||||||
| 10/05/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/29/2023 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 911 | 1,729 | $244,335 | $86,856 |
| 2022 | 6 | 392 | 567 | $65,160 | $27,044 |
| 2021 | 5 | 316 | 461 | $47,076 | $26,546 |
Total Patients
1,619
Total Services
2,757
Medicare Billing
$140,446
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 243 | 416 | $80,970 | $27,083 | 33.4% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2023 | 125 | 171 | $27,360 | $12,733 | 46.5% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 18 | 273 | $16,380 | $9,388 | 57.3% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2023 | 160 | 229 | $22,900 | $7,599 | 33.2% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 30 | 82 | $20,500 | $7,454 | 36.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $22,550 | $6,654 | 29.5% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 11 | 42 | $6,300 | $2,889 | 45.9% |
| 11755 | Biopsy of fingernail or toenail | Office | 2023 | 21 | 22 | $6,600 | $1,775 | 26.9% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 18 | 49 | $2,940 | $1,685 | 57.3% |
| 96921 | Treatment of inflammatory skin disease using laser, 250.0-500.0 sq cm | Office | 2023 | 13 | 13 | $4,550 | $1,593 | 35.0% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2023 | 40 | 51 | $3,825 | $1,310 | 34.2% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 13 | 13 | $3,900 | $1,299 | 33.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 18 | 22 | $6,600 | $1,044 | 15.8% |
| 97032 | Application of electrical stimulation with therapist present, each 15 minutes | Office | 2023 | 13 | 103 | $6,155 | $976.34 | 15.9% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 18 | 21 | $1,260 | $722.19 | 57.3% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 13 | 17 | $3,040 | $597.90 | 19.7% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 11 | 13 | $4,965 | $556.96 | 11.2% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 11 | 14 | $840.00 | $481.46 | 57.3% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 11 | 14 | $840.00 | $481.46 | 57.3% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 11 | 14 | $840.00 | $481.46 | 57.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 31 | 68 | $1,020 | $52.24 | 5.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 168 | 268 | $38,045 | $15,572 | 40.9% |
| 11721 | Removal of fingernails or toenails, 6 or more nails | Office | 2022 | 100 | 136 | $9,662 | $4,185 | 43.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 45 | 45 | $7,810 | $2,656 | 34.0% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 25 | 30 | $4,693 | $2,449 | 52.2% |
About Dr. Bilal Master, DPM
Dr. Bilal Master, DPM is a Foot & Ankle Surgery healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2018. The National Provider Identifier (NPI) number assigned to this provider is 1588156756.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bilal Master, DPM has received a total of $3,264 in payments from pharmaceutical and medical device companies, with $558.60 received in 2024. These payments were reported across 65 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,549).
As a Medicare-enrolled provider, Master has provided services to 1,619 Medicare beneficiaries, totaling 2,757 services with total Medicare billing of $140,446. Data is available for 3 years (2021–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Foot & Ankle Surgery
- Location Plano, TX
- Active Since 06/04/2018
- Last Updated 12/12/2023
- Taxonomy Code 213ES0103X
- Entity Type Individual
- NPI Number 1588156756
Products in Payments
- KRYSTEXXA (Biological) $154.32
- ACell (Device) $146.68
- DART-FIRE (Device) $143.72
- NUZYRA (Drug) $133.87
- DALVANCE (Drug) $131.51
- 3C Patch Kit - Box (Device) $128.08
- Kerecis Omega3 SurgiClose (Device) $97.61
- AUGMENT INJECTABLE (Device) $56.83
- QUTENZA (Drug) $54.16
- TEFLARO (Drug) $48.24
- JUBLIA (Drug) $44.97
- Puraply (Medical Supply) $38.04
- IRRISEPT (Device) $34.71
- COLLAGENASE SANTYL (Drug) $29.60
- REGRANEX (Drug) $20.29
- ORTHOLOC 3DI (Device) $20.00
- RENASYS GO v2 HOME (Device) $16.90
- Senza (Device) $14.01
- CADENCE (Device) $13.58
- ACTISHIELD (Device) $12.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Foot & Ankle Surgery Doctors in Plano
Hope Jacoby, Dpm, DPM
Foot & Ankle Surgery — Payments: $25,366
Foot & Ankle Surgery $25,366
Charles Marder, Dpm, DPM
Foot & Ankle Surgery — Payments: $22,698
Foot & Ankle Surgery $22,698
Dr. John Baca, D.p.m, D.P.M
Foot & Ankle Surgery — Payments: $21,997
Foot & Ankle Surgery $21,997
Rekha Kouri, Dpm, DPM
Foot & Ankle Surgery — Payments: $17,723
Foot & Ankle Surgery $17,723
Jaryl Korpinen, Dpm, DPM
Foot & Ankle Surgery — Payments: $13,551
Foot & Ankle Surgery $13,551
Jeremiah Graff, Dpm, DPM
Foot & Ankle Surgery — Payments: $12,868
Foot & Ankle Surgery $12,868